Benzodiazepine Use in Pregnancy and the Risk of Pregnancy Outcomes
JAMA Internal Medicine 10.1001/jamainternmed.2025.6882December 22, 2025 at 11:00 AM EST
Is the use of benzodiazepine during pregnancy, compared with nonuse, associated with different risks of preterm birth and small for gestational age, while considering the risks of abortion and stillbirth?In this cohort study of 454 477 pregnancies, among live births, benzodiazepine use was associated with reduced risks of preterm birth and small for gestational age after adjusting for all measured confounders; however, benzodiazepine use was associated with an increased risk of abortion. After accounting for competing risks, benzodiazepine use was associated with increased risks of preterm birth and small for gestational age, with more pronounced effects observed after exposure during the second trimester.The findings of this study, after considering the association of competing events, suggested that benzodiazepine use was associated with increased risks of preterm birth and may also be associated with an increased risk of small for gestational age; however, the latter association was small and sensitive to the analytic method.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.